Goldman Sachs Group Inc. Trims Stock Position in TrueBlue, Inc. $TBI

Key Points

• Goldman Sachs Group Inc. has reduced its holdings in TrueBlue, Inc. by 31.5%, now owning approximately 0.36% of the company, valued at $578,000.
• TrueBlue reported a loss of ($0.07) earnings per share, surpassing the consensus estimate of ($0.31), with a revenue of $396.30 million for the last quarter.
• BMO Capital Markets revised its target price for TrueBlue from $7.00 to $8.00, with a consensus rating of "Buy".

Goldman Sachs Group Inc. trimmed its holdings in shares of TrueBlue, Inc. (NYSE:TBI - Free Report) by 31.5% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 108,906 shares of the business services provider's stock after selling 49,969 shares during the period. Goldman Sachs Group Inc. owned about 0.36% of TrueBlue worth $578,000 as of its most recent SEC filing.

Several other institutional investors have also recently modified their holdings of TBI. GAMMA Investing LLC grew its holdings in TrueBlue by 217.2% during the 1st quarter. GAMMA Investing LLC now owns 8,135 shares of the business services provider's stock valued at $43,000 after buying an additional 5,570 shares during the last quarter. XTX Topco Ltd purchased a new stake in shares of TrueBlue in the first quarter valued at $86,000. AE Wealth Management LLC lifted its position in shares of TrueBlue by 55.2% in the first quarter. AE Wealth Management LLC now owns 19,616 shares of the business services provider's stock valued at $104,000 after acquiring an additional 6,973 shares in the last quarter. Dynamic Technology Lab Private Ltd acquired a new stake in shares of TrueBlue during the first quarter valued at $156,000. Finally, Boston Partners increased its position in TrueBlue by 29.9% during the 1st quarter. Boston Partners now owns 40,978 shares of the business services provider's stock worth $218,000 after purchasing an additional 9,433 shares in the last quarter. 97.15% of the stock is currently owned by institutional investors and hedge funds.

TrueBlue Stock Down 1.9%

TBI opened at $6.25 on Friday. TrueBlue, Inc. has a 12 month low of $3.45 and a 12 month high of $9.05. The business has a 50-day moving average of $6.29 and a two-hundred day moving average of $5.83. The company has a debt-to-equity ratio of 0.18, a current ratio of 1.94 and a quick ratio of 1.94. The stock has a market capitalization of $186.88 million, a price-to-earnings ratio of -5.43 and a beta of 1.54.

TrueBlue (NYSE:TBI - Get Free Report) last released its earnings results on Monday, August 4th. The business services provider reported ($0.07) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.31) by $0.24. The business had revenue of $396.30 million for the quarter, compared to analysts' expectations of $400.52 million. TrueBlue had a negative net margin of 2.21% and a negative return on equity of 5.74%. TrueBlue has set its Q3 2025 guidance at EPS. On average, research analysts expect that TrueBlue, Inc. will post 0.15 earnings per share for the current year.

Analyst Ratings Changes

Separately, BMO Capital Markets upped their target price on shares of TrueBlue from $7.00 to $8.00 and gave the company an "outperform" rating in a report on Wednesday, August 6th. One equities research analyst has rated the stock with a Buy rating, According to data from MarketBeat.com, the company has a consensus rating of "Buy" and a consensus target price of $8.00.

About TrueBlue

TrueBlue, Inc, together with its subsidiaries, provides specialized workforce solutions in the United States, Canada, the United Kingdom, Australia, and Puerto Rico. It operates through three segments: PeopleReady, PeopleManagement, and PeopleScout. The company PeopleReady segment provides general, industrial, and skilled trade contingent staffing services for construction, transportation, manufacturing, retail, hospitality, and renewable energy industries.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.